Vinay Khandelwal

Vinay Khandelwal

Active Director Director DIN 07790399
DIN 07790399 First appointment Aug 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Aug 2017
Shareholding value •••• Premium profile

About Vinay Khandelwal

Data last updated:

Vinay Khandelwal is a Director at Auracare Pharma Private Limited (since 2017), Director at Viralii Life Sciences Private Limited (since 2018) and Director at Aukea Life Sciences Private Limited (since 2019), and holds 1 more current directorship. The companies operate in Trading and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹116 Cr; the largest is Auracare Pharma Private Limited at ₹111 Cr (FY 2025). Earlier, Vinay Khandelwal was a Director at Ratnagene Lifescience Private Limited (from 2022).

DIN 07790399
Primary Designation Director
Industry Trading
First Appointment 02 Aug 2017
Oldest Company Age 9 yrs
Largest company Auracare Pharma Private Limited · ₹111 Cr (FY 2025)
Combined revenue ₹116 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Auracare Pharma Private Limited U74999GJ2017PTC098536
Director02 Aug 20172017₹111 Cr (FY 2025)Active
Director06 Apr 20182018₹4.79 Cr (FY 2024)Active
Aukea Life Sciences Private Limited U24303GJ2019PTC107528
Director09 Apr 20192019₹11 Lakh (FY 2022)Active
Vitex Laboratories Private Limited U21000TS2025PTC200684
Director03 Jul 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20222021₹1.98 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ratnagene Lifescience Private Limited
Aukea Life Sciences Private Limited
Auracare Pharma Private Limited
Viralii Life Sciences Private Limited
Premium access

Shareholding and investment profile for Vinay Khandelwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vinay Khandelwal

Vinay Khandelwal currently holds 4 directorships: Auracare Pharma Private Limited (Director, since 02 Aug 2017, revenue ₹111 Cr (FY 2025)); Viralii Life Sciences Private Limited (Director, since 06 Apr 2018, revenue ₹4.79 Cr (FY 2024)); Aukea Life Sciences Private Limited (Director, since 09 Apr 2019, revenue ₹11 Lakh (FY 2022)); Vitex Laboratories Private Limited (Director, since 03 Jul 2025).

Vinay Khandelwal was first appointed on 02 Aug 2017 as Director at Auracare Pharma Private Limited. The most recent appointment on record is 03 Jul 2025 at Vitex Laboratories Private Limited.

The 3 current companies of Vinay Khandelwal that report revenue have a combined latest revenue of ₹116 Cr: Auracare Pharma Private Limited ₹111 Cr (FY 2025); Viralii Life Sciences Private Limited ₹4.79 Cr (FY 2024); Aukea Life Sciences Private Limited ₹11 Lakh (FY 2022).

Vinay Khandelwal held 1 earlier board appointment: Ratnagene Lifescience Private Limited (Director, from 01 Sep 2022).

The current boards of Vinay Khandelwal's companies include Gurmeet Singh Jolly (Auracare Pharma Private Limited), Shalu Khandelwal (Auracare Pharma Private Limited), Arup Ajitkumar Roy (Viralii Life Sciences Private Limited), Amrut Nathalal Chaudhari (Aukea Life Sciences Private Limited), Mukeshkumar Dhirajlal Soni (Aukea Life Sciences Private Limited), Srinivasulu Chowdary Kavuturu (Vitex Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available